ArticleWomen's health reports (New Rochelle, N.Y.)
Does Folic Acid Intake Play Role as a Potential Indicator of Modifiable Maternal Risk Factors in Preconception Period?: A Cross-Sectional Study.
Article in Women's health reports (New Rochelle, N.Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Folic acid is essential for preventing neural tube defects and for normal fetal development. This study aims to evaluate the rate and trends of folic acid intake among women completing the questionnaire to enroll in the preconception care program and examine its role as a potential indicator associated with modifiable biomedical, behavioral, and social health risk factors. Methods: This is a cross-sectional study. A total of 42,730 women seeking to enroll in preconception care program of Seoul City, Korea, between Nov. 2017 and Dec. 2023. Folic acid intake among women planning pregnancy and modifiable risk factors, including biomedical, behavioral, and social risks, were obtained from an organized questionnaire on online. We exclude cases having incomplete data for analysis. Results: The proportion of participants taking folic acid is 35.1% (15,003/42,730).Factors associated with greater folic acid use included advanced maternal age, higher body mass index, greater gravidity, previous spontaneous abortion, previous artificial abortion, regular exercise, and higher family income. Conversely, factors associated with less folic acid use included depression, insomnia, bulimia, social drinking, positive screening for risky drinking, cigarette smoking, unmarried status, and white-collar employment. Conclusions: Our study found that folic acid intake during the preconception period remains low at 35.1%. Annual trends show the modest improvement but remain insufficient. And preconception folic acid intake was significantly associated with greater or lesser likelihoods of several modifiable biomedical, behavioral, and social risk factors. Therefore, folic acid use may serve as a surrogate marker of health awareness and engagement in preconception care. Future studies should assess folic acid as a marker of preconception care effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.